DermatologyNCT06854419
Efficacy Evaluation of Blood Peach Extract and Rose Apple Extract on Skin
A study testing Blood Peach Extract Drink and Rose Apple Extract Drink in people with Dermatology, run by TCI Co., Ltd. at 1 site in Taiwan.
Trial summary
Evaluate the effects of blood peach extract drink and rose apple extract drink on enhancing hemoglobin and iron levels, and improving skin health. Read more about this study
- Who is it for?
- Ages 20 to 65 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Dermatology
- What is being tested?
- Blood Peach Extract Drink and Rose Apple Extract Drink
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 75 participants
- Where
- 1 siteTaiwan
- Study dates
- 7 Apr 2025to 15 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 65 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy adult females aged 20 to 65;
- Preferably those with pale complexion or signs of iron deficiency anemia.
Who cannot join
- Currently undergoing or having undergone any medical beauty treatments within the past month (including skincare, laser treatments, chemical peel, injections, or cosmetic surgery);
- Outdoor workers (exposed to sunlight for more than 5 hours daily);
- Pregnant, breastfeeding, or planning to become pregnant during the trial (self-reported);
- Individuals with heart, liver, kidney, endocrine, or other significant organic diseases (self-reported);
- Individuals who have undergone major surgery (according to medical history);
- Long-term medication users;
Show all 9Show fewer
- Individuals with mental health disorders;
- Those who are already regularly taking iron supplements;
- Faculty or staff members who are currently enrolled in the principal investigator's courses.
Trial locations and contacts
1 site in 1 country.
Taiwan1 site
China Medical University of Department of Cosmeceutics
Taichung, 406040
About this study
Evaluate the effects of blood peach extract drink and rose apple extract drink on enhancing hemoglobin and iron levels, and improving skin health.
- Conditions
- Dermatology
- Being tested
- Placebo Drink, Blood Peach Extract Drink, Rose Apple Extract Drink
- Keywords
- skin analysis, skin care products
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Placebo DrinkDietary supplement
Take one bottle of the product every morning on an empty stomach
Blood Peach Extract DrinkDietary supplement
Take one bottle of the product every morning on an empty stomach
Rose Apple Extract DrinkDietary supplement
Take one bottle of the product every morning on an empty stomach
| Study group | Role | What they receive |
|---|---|---|
| Placebo | Placebo comparator | Not described Receives: Dietary Supplement: Placebo Drink |
| Blood Peach Extract | Experimental | Not described Receives: Dietary Supplement: Blood Peach Extract Drink |
| Rose Apple Extract | Experimental | Not described Receives: Dietary Supplement: Rose Apple Extract Drink |
What is being measured
The primary outcome is the main question the study is designed to answer.
the volume of skin wrinkles
IRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units
Measured: Volume change from Baseline skin wrinkles at 8 weeks
the roughness of skin texture
IRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units
Measured: Rating skin roughness from Baseline skin texture at 8 weeks
Secondary outcomes (16)
the change of skin elasticity
Cutometer® was utilized to measure skin elasticity. Units: arbitrary units
Measured: Change from Baseline skin elasticity at 8 weeks
the change of skin collagen density
Dermalab® Combo was utilized to measure skin collagen density. Units: arbitrary units
Measured: Change from Baseline skin collagen density at 8 weeks
the change of skin pores
IRV full-face skin analyzer was utilized to measure skin pores. Units: arbitrary units
Measured: Change from Baseline skin pores at 8 weeks
the change of skin tone
IRV full-face skin analyzer was utilized to measure skin tone. Units: arbitrary units
Measured: Change from Baseline skin tone at 8 weeks
the change of skin hydration
Corneometer® was utilized to measure skin hydration. Units: arbitrary units
Measured: Change from Baseline skin hydration at 8 weeks
the change of skin melanin/erythema index
Mexameter® was utilized to measure skin melanin/erythema index. Units: arbitrary units
Measured: Change from Baseline skin melanin/erythema index at 8 weeks
the change of skin redness
Colorimeter was utilized to measure skin redness. Units: arbitrary units
Measured: Change from Baseline skin redness at 8 weeks
the change of lip redness
Antera 3D® was utilized to measure lip redness. Units: arbitrary units
Measured: Change from Baseline lip redness at 8 weeks
the change of Red Blood Cells (RBC) Count of blood
venous blood was sampled to measure RBC count
Measured: Change from Baseline RBC count at 8 weeks
the change of hemoglobin level of blood
venous blood was sampled to measure hemoglobin level
Measured: Change from Baseline hemoglobin level at 8 weeks
the change of mean corpuscular volume (M.C.V) level of blood
venous blood was sampled to measure M.C.V level
Measured: Change from Baseline M.C.V level at 8 weeks
the change of mean corpuscular hemoglobin concentration (M.C.H.C) level of blood
venous blood was sampled to measure M.C.H.C level
Measured: Change from Baseline M.C.H.C level at 8 weeks
the change of ferrous level of blood
venous blood was sampled to measure ferrous level
Measured: Change from Baseline ferrous level at 8 weeks
the change of ferritin level of blood
venous blood was sampled to measure ferritin level
Measured: Change from Baseline ferritin level at 8 weeks
the change of Total Iron Binding Capacity (TIBC) level of blood
venous blood was sampled to measure TIBC level
Measured: Change from Baseline TIBC level at 8 weeks
the change of unsaturated iron-binding capacity (UIBC) level of blood
venous blood was sampled to measure UIBC level
Measured: Change from Baseline UIBC level at 8 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Mar 2025
- Study start7 Apr 2025
- Primary completion30 Jun 2025
- Study completion15 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DermatologyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 75 participants (actual)
Sponsor and investigators
- Lead sponsor
- TCI Co., Ltd.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Hsiu-Mei Chiang, Principal investigator, China Medical University of Department of Cosmeceutics
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06854419
- Sponsor's protocol ID
- CMUH114-REC3-005
- Status last verified
- Jul 2025
- First submitted
- 25 Feb 2025
- Last updated
- 30 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy Evaluation of Blood Peach Extract and Rose Apple Extract on Skin
- ClinicalTrials.gov ID
- NCT06854419
- Acronym / sponsor ID
- CMUH114-REC3-005
- Conditions
- Dermatology
- Keywords
- skin analysis, skin care products
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 75 participants (actual)
- Lead sponsor
- TCI Co., Ltd.Industry (pharma, biotech, devices)
- Study start
- 7 Apr 2025 (actual)
- Primary completion
- 30 Jun 2025 (actual)
- Study completion
- 15 Jul 2025 (actual)
- First posted
- 3 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluate the effects of blood peach extract drink and rose apple extract drink on enhancing hemoglobin and iron levels, and improving skin health.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Placebo | Placebo comparator | Dietary Supplement: Placebo Drink |
| Blood Peach Extract | Experimental | Dietary Supplement: Blood Peach Extract Drink |
| Rose Apple Extract | Experimental | Dietary Supplement: Rose Apple Extract Drink |
Who may qualify
- Ages
- 20 to 65 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Healthy adult females aged 20 to 65;
- Preferably those with pale complexion or signs of iron deficiency anemia.
Key exclusion criteria (9 listed)
- Currently undergoing or having undergone any medical beauty treatments within the past month (including skincare, laser treatments, chemical peel, injections, or cosmetic surgery);
- Outdoor workers (exposed to sunlight for more than 5 hours daily);
- Pregnant, breastfeeding, or planning to become pregnant during the trial (self-reported);
- Individuals with heart, liver, kidney, endocrine, or other significant organic diseases (self-reported);
- Individuals who have undergone major surgery (according to medical history);
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Placebo DrinkTake one bottle of the product every morning on an empty stomach | Dietary supplement | Placebo |
| Blood Peach Extract DrinkTake one bottle of the product every morning on an empty stomach | Dietary supplement | Blood Peach Extract |
| Rose Apple Extract DrinkTake one bottle of the product every morning on an empty stomach | Dietary supplement | Rose Apple Extract |
Primary outcome
the volume of skin wrinkles
Time frame: Volume change from Baseline skin wrinkles at 8 weeks
IRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units
the roughness of skin texture
Time frame: Rating skin roughness from Baseline skin texture at 8 weeks
IRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units
16 secondary outcomes
the change of skin elasticity
Time frame: Change from Baseline skin elasticity at 8 weeks
the change of skin collagen density
Time frame: Change from Baseline skin collagen density at 8 weeks
the change of skin pores
Time frame: Change from Baseline skin pores at 8 weeks
the change of skin tone
Time frame: Change from Baseline skin tone at 8 weeks
the change of skin hydration
Time frame: Change from Baseline skin hydration at 8 weeks
the change of skin melanin/erythema index
Time frame: Change from Baseline skin melanin/erythema index at 8 weeks
the change of skin redness
Time frame: Change from Baseline skin redness at 8 weeks
the change of lip redness
Time frame: Change from Baseline lip redness at 8 weeks
the change of Red Blood Cells (RBC) Count of blood
Time frame: Change from Baseline RBC count at 8 weeks
the change of hemoglobin level of blood
Time frame: Change from Baseline hemoglobin level at 8 weeks
the change of mean corpuscular volume (M.C.V) level of blood
Time frame: Change from Baseline M.C.V level at 8 weeks
the change of mean corpuscular hemoglobin concentration (M.C.H.C) level of blood
Time frame: Change from Baseline M.C.H.C level at 8 weeks
the change of ferrous level of blood
Time frame: Change from Baseline ferrous level at 8 weeks
the change of ferritin level of blood
Time frame: Change from Baseline ferritin level at 8 weeks
the change of Total Iron Binding Capacity (TIBC) level of blood
Time frame: Change from Baseline TIBC level at 8 weeks
the change of unsaturated iron-binding capacity (UIBC) level of blood
Time frame: Change from Baseline UIBC level at 8 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Dermatology
RecruitingPhase 3
Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis
Atopic Dermatitis, Atopic Dermatitis (AD)
Recruiting
Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care
Skin Cancer Prevention, Melanoma In Situ
Not yet recruiting
Human-AI Uncertainty Callibration for Improved Skin Lesion Segmentation
Skin Lesions
Active, not recruitingObservational study
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
New Patient Use of Teledermatology Mobile App
RecruitingPhase 3
Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne Vulgaris
Acne Vulgaris, Acne Vulgaris on the Face
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hsiu-Mei Chiang principal investigator
China Medical University of Department of Cosmeceutics
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Blood Peach Extract Drink and Rose Apple Extract Drink in people with Dermatology, run by TCI Co., Ltd. at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
the volume of skin wrinkles (time frame: Volume change from Baseline skin wrinkles at 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025.